Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.66 - $5.61 $26,600 - $56,100
-10,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.18 - $8.48 $51,800 - $84,800
10,000 New
10,000 $53,000
Q3 2021

Nov 15, 2021

SELL
$8.46 - $12.42 $235,128 - $345,189
-27,793 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$12.19 - $28.17 $338,796 - $782,928
27,793 New
27,793 $339,000

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $82.5M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.